An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Autor principal: | Bristy, Israt Zerin |
---|---|
Outros Autores: | Kabir, Md. Tanvir |
Formato: | Thesis |
Idioma: | English |
Publicado em: |
Brac University
2021
|
Assuntos: | |
Acesso em linha: | http://hdl.handle.net/10361/15619 |
Registos relacionados
-
Molecules associated with the development of lung cancer
Por: Rahman, Adree, et al.
Publicado em: (2023) -
A case study of lung cancer patients in term of various risk factors in context of Bangladesh
Por: Shabnam, Musharrat
Publicado em: (2018) -
Immunotherapy in the Management of Lung Cancer
Por: Tasnim, Humayra
Publicado em: (2022) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
Por: Paul, Pulock
Publicado em: (2024) -
Potential of liposomes for the treatment of lung cancer- a review
Por: Mim, Shanzida
Publicado em: (2023)